The CD1d natural killer T-cell antigen presentation pathway is highly conserved between humans and rhesus macaques

被引：19
|
作者：
Kashiwase, K
Kikuchi, A
Ando, Y
Nicol, A
Porcelli, SA
Tokunaga, K
Omine, M
Satake, M
Juji, T
Nieda, M [1 ]
Koezuka, Y
机构：
[1] MEDINET Co Ltd, Lab Mol Immunol, Tokyo, Japan
[2] Japanese Red Cross Tokyo Metropolitan Blood Ctr, Dept Lab, Tokyo, Japan
[3] Japanese Red Cross Cent Blood Ctr, Dept Res, Tokyo, Japan
[4] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan
[5] Univ Queensland, Dept Med, Queensland Inst Med Res, Brisbane, Qld 4000, Australia
[6] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[7] Showa Univ, Fujigaoka Hosp, Ctr Blood, Yokohama, Kanagawa 227, Japan
[8] Kirin Brewery Co Ltd, Pharmaceut Res Lab, Gunma, Japan
来源：
IMMUNOGENETICS | 2003年 / 54卷 / 11期
关键词：
alpha-GalCer; CD1d; V alpha 24NKT; rhesus macaque; nonhuman primate;
D O I：
10.1007/s00251-002-0527-8
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Natural killer T (NKT) cells play an important role in controlling cancers, infectious diseases and autoimmune diseases. Although the rhesus macaque is a useful primate model for many human diseases such as infectious and autoimmune diseases, little is known about their NKT cells. We analyzed Valpha24TCR+ T cells from rhesus macaque peripheral blood mononuclear cells stimulated with aalpha-galactosylceramide (a-GalCer) and interleukin-2. We found that rhesus macaques possess Va24TCR+ T cells, suggesting that recognition of alpha-GalCer is highly conserved between rhesus macaques and humans. The amino acid sequences of the V-J junction for the Valpha24TCR of rhesus macaque and human NKT cells are highly conserved (93% similarity), and the CD1d alpha1-alpha2 domains of both species are highly homologous (95.6%). These findings indicate that the rhesus macaque is a useful primate model for understanding the contribution of NKT cells to the control of human diseases.
引用
收藏
页码：776 / 781
页数：6
相关论文
共 50 条
  • [31] The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction
    M. Virginia Gentilini
    M. Eugenia Pérez
    Pablo Mariano Fernández
    Leonardo Fainboim
    Eloísa Arana
    Cancer Immunology, Immunotherapy, 2016, 65 : 551 - 562
  • [32] The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction
    Virginia Gentilini, M.
    Eugenia Perez, M.
    Mariano Fernandez, Pablo
    Fainboim, Leonardo
    Arana, Eloisa
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (05) : 551 - 562
  • [33] Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells
    Shyanti, Ritis K.
    Sehrawat, Anuradha
    Singh, Shivendra V.
    Mishra, J. P. N.
    Singh, Rana P.
    TOXICOLOGY IN VITRO, 2017, 44 : 74 - 84
  • [34] Evidence of a functional CD1d lipid antigen presentation pathway in murine alveolar epithelial cells
    Rizvi, Zaigham
    Puri, Niti
    Saxena, Rajiv
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [35] Epstein-Barr virus downregulates B cell surface CD1d to evade natural killer T cell detection
    Chung, Brian
    Allan, Lenka
    Zheng, Dong Jun
    Priatel, John
    van den Elzen, Peter
    Tan, Rusung
    CLINICAL IMMUNOLOGY, 2008, 127 : S135 - S136
  • [36] Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens
    Le Nours, Jerome
    Praveena, T.
    Pellicci, Daniel G.
    Gherardin, Nicholas A.
    Ross, Fiona J.
    Lim, Ricky T.
    Besra, Gurdyal S.
    Keshipeddy, Santosh
    Richardson, Stewart K.
    Howell, Amy R.
    Gras, Stephanie
    Godfrey, Dale I.
    Rossjohn, Jamie
    Uldrich, Adam P.
    NATURE COMMUNICATIONS, 2016, 7
  • [37] CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies
    Melo, Ashanty M.
    Conroy, Melissa J.
    Foley, Emma K.
    Dockry, Eilis
    Breen, Eamon P.
    Reynolds, John, V
    Lysaght, Joanne
    Doherty, Derek G.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (06) : 969 - 982
  • [38] CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies
    Ashanty M. Melo
    Melissa J. Conroy
    Emma K. Foley
    Éilis Dockry
    Eamon P. Breen
    John V. Reynolds
    Joanne Lysaght
    Derek G. Doherty
    Cancer Immunology, Immunotherapy, 2020, 69 : 969 - 982
  • [39] Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus) (vol 146, pg 618, 2015)
    Fichtner, A. S.
    Paletta, D.
    Starick, L.
    Schumann, R. F.
    Niewiesk, Stefan
    Herrmann, Thomas
    IMMUNOLOGY, 2016, 147 (02)
  • [40] Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
    Gumperz, JE
    Miyake, S
    Yamamura, T
    Brenner, MB
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05): : 625 - 636
12345